Angiotensin II (3-8), human is a less effective agonist at the angiotensin AT1 receptor.
CAT No: R1201
CAS No:12676-15-2
Synonyms/Alias:Angiotensin IV;12676-15-2;23025-68-5;Angiotensin II (3-8), human;Human angiotensin IV;Nle-angiv;VAL-TYR-ILE-HIS-PRO-PHE;Ile3-angiotensin IV;Huamn angiotensin (3-8);1-De-asp-2-de-arg-5-ile-angiotensin II;(Ile5)-angiotensin II (3-8);(3-8)-5-Isoleucine-angiotensin II;Human angiotensin hexapeptide (3-8);(2S)-2-[[(2S)-1-[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-amino-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylpentanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]pyrrolidine-2-carbonyl]amino]-3-phenylpropanoic acid;angiotensin II, des-Asp(1)-des-Arg(2)-Ile(5)-;(Des(Asp1,Arg2)-Ile5)angiotensin II;(Isoleucine5)-angiotensin II hexapeptide;3-L-isoleucine-Angiotensin IV;CHEMBL261120;5-Isoleucine-angiotensin II 3-8-hexapeptide;Angiotensin II, des-aspartyl(1)-des-arginyl(2)-isoleucine(5)-;Angiotensin IV, 3-L-isoleucine-;AT II (3-8);Angiotensin IV trifluoroacetate salt;Alanine, 3-phenyl-N-(1-(N-(N-(N-valyltyrosyl)isoleucyl)histidyl)prolyl)-;Angiotensin II, 1-de-L-aspartic acid-2-de-L-arginine-5-L-isoleucine-;Angiotensin II (3-8);Alanine, 3-phenyl-N-(1-(N-(N-(N-L-valyl-L-tyrosyl)-L-isoleucyl)-L-histidyl)-L-prolyl)-;(2S)-2-{[(2S)-1-[(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-(4-hydroxyphenyl)propanamido]-3-methylpentanamido]-3-(1H-imidazol-5-yl)propanoyl]pyrrolidin-2-yl]formamido}-3-phenylpropanoic acid;Ang IV;MLS000069773;Angiotensin II, 1-des-asn-2-arg;(2S)-2-((((2S)-1-((2S)-2-(((2S,3S)-2-(((2S)-2-(((2S)-2-amino-1-hydroxy-3-methylbutylidene)amino)-1-hydroxy-3-(4-hydroxyphenyl)propylidene)amino)-1-hydroxy-3-methylpentylidene)amino)-3-(1H-imidazol-5-yl)propanoyl)pyrrolidin-2-yl)(hydroxy)methylidene)amino)-3-phenylpropanoate;(2S)-2-(((2S)-1-((2S)-2-((2S,3S)-2-((2S)-2-((2S)-2-amino-3-methylbutanamido)-3-(4-hydroxyphenyl)propanamido)-3-methylpentanamido)-3-(1H-imidazol-5-yl)propanoyl)pyrrolidin-2-yl)formamido)-3-phenylpropanoic acid;(2S)-2-({[(2S)-1-[(2S)-2-{[(2S,3S)-2-{[(2S)-2-{[(2S)-2-amino-1-hydroxy-3-methylbutylidene]amino}-1-hydroxy-3-(4-hydroxyphenyl)propylidene]amino}-1-hydroxy-3-methylpentylidene]amino}-3-(1H-imidazol-5-yl)propanoyl]pyrrolidin-2-yl](hydroxy)methylidene}amino)-3-phenylpropanoate;MFCD00167496;(A)II(3-8);cid_123814;GTPL5368;SCHEMBL4322236;BDBM85550;CHEBI:80127;DTXSID701347717;HMS2232C15;1-De-L-aspartic -2-de-L-arginine-5-L-isoleucineangiotensin II;HY-P1515;AKOS040758825;NCGC00167590-02;DA-50481;FA110283;SMR000058913;CAS_12676-15-2;CS-0044614;G83766;H-Val-Tyr-Ile-His-Pro-Phe-OH; H-VYIHPF-OH;Q66087802;Angiotensin I/II (3-8) (H-Val-Tyr-Ile-His-Pro-Phe-OH);1-De-L-aspartic-2-de-L-arginine-5-L-isoleucineangiotensin II;Angiotensin IV trifluoroacetate salt, >=95% (HPLC), powder;valyl-l-tyrosyl-l-isoleucyl-l-histidyl-l-prolyl-l-phenylalanin;(2S)-2-{[(2S)-1-[(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-AMINO-3-METHYLBUTANAMIDO]-3-(4-HYDROXYPHENYL)PROPANAMIDO]-3-METHYLPENTANAMIDO]-3-(1H-IMIDAZOL-4-YL)PROPANOYL]PYRROLIDIN-2-YL]FORMAMIDO}-3-PHENYLPROPANOIC ACID;(S)-2-((S)-1-((S)-2-((2S,3S)-2-((S)-2-((S)-2-amino-3-methylbutanamido)-3-(4-hydroxyphenyl)propanamido)-3-methylpentanamido)-3-(1H-imidazol-4-yl)propanoyl)pyrrolidine-2-carboxamido)-3-phenylpropanoic acid;
1. Implications of ligand-receptor binding kinetics on GLP-1R signalling
3. Peptides as Active Ingredients: A Challenge for Cosmeceutical Industry
4. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.